Facebook
Twitter
LinkedIn
ForwardPractical Medicine: Cardiometabolic Disease – Interview with the Experts and Risk Factor Management – Practical Tips for Busy Practitioners
Peak into the minds of leading experts in cardiovascular disease prevention as they analyze common clinical scenarios and clarify how they would address residual risk, lifestyle intervention, nutrition, pharmaceutical interventions, current guidelines, Omega-3s and other pertinent topics in the area of cardiometabolic disease during two round table discussions.
Target Audience
Cardiologists, General Internists, Family Physicians, Emergency Medicine Physicians, Urgent Care Physicians, Obstetricians, Gynecologists, Nurse Practitioners, Physician Assistants, and all other healthcare professionals who care for patients who wish to prevent – or who have been diagnosed with – cardiological, vascular or metabolic risks, disorders or diseases.
Learning Objective:
- Utilize current evidence-based cardiovascular disease prevention guidelines and apply them when presented with challenging cardiovascular disease scenarios in clinical practice.
Christie M. Ballantyne, M.D.
Vice-chair, Research, Department of Medicine
Chief, Cardiology and Cardiovascular Research
Director, Center for Cardiometabolic Disease Prevention’s Lipid Metabolism and Atherosclerosis Clinic
Baylor College of Medicine
Houston, Texas
Michael J. Blaha, M.D., MPH
Director, Clinical Research
Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
Researcher, Clinical Epidemiology
Faculty Appointments, Cardiology and Epidemiology
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
Member, Statistics and Fellow-in-Training/Early Career Committees
American Heart Association
Roger Blumenthal, M.D.
Director, Preventive Cardiology
Johns Hopkins Bloomberg School of Public Health
Member, National Spokesperson Panel
Co-chair, Prevention Subcommittee
Baltimore, Maryland
Co-chair, ACC/AHA Guidelines Committee
American Heart Association
Theodore Feldman, M.D.
Medical Director, Miami Cardiac & Vascular Institute at South Miami Hospital
Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Clinical Associate Professor of Medicine
Cardiology Clerkship Director
Interviewer, Medical School Admissions Committee
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Michael Ozner, M.D., FACC, FAHA
Moderator
Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Voluntary Associate Clinical Professor of Cardiology
University of Miami Miller School of Medicine
Miami, Florida
Christie M. Ballantyne, M.D., has disclosed that he receives grant/research support from Abbott Diagnostic, Amarin, Amgen, Esperion, Ionis, Novartis Pharmaceuticals, Pfizer Pharmaceuticals, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, National Institutes of Health, American Heart Association and American Diabetes Association. Also, Dr. Ballantyne serves as a consultant to Abbott Diagnostic, Amarin, Amgen, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Eli Lilly, Esperion, Ionis, Matinas BioPharma, Inc., Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer Pharmaceuticals, Regeneron, Roche Diagnostic and Sanofi-Synthelabo. Dr. Ballantyne has disclosed that his presentations will include discussion of off-label or unapproved usage.
Michael J. Blaha, M.D., has disclosed that he is a member of the advisory boards for MedImmune, Novartis Pharmaceuticals, Amgen and Sanofi/Regeneron. Dr. Blaha has indicated that his presentation will not include discussion of off-label or unapproved usage.
Roger Blumenthal, M.D., has indicated that neither he nor his spouses/partners have relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentation or discussion.
Theodore Feldman, M.D., has stated that he is on the speakers' bureau of Regeneron/Sanofi, Novartis Pharmaceuticals and Boehringer Ingelheim Pharmaceuticals. Dr. Feldman has indicated that his presentation will not include discussion of off-label or unapproved usage.
Michael D. Ozner, M.D., has disclosed that he is a member of the scientific advisory board for the Life Extension Foundation and author of the books The Great American Heart Hoax, Heart Attack Proof and The Complete Mediterranean Diet. Dr. Ozner has indicated that his presentation will not include discussion of off-label or unapproved usage.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.75 AMA PRA Category 1 Credit™
- 1.75 General certificate of attendance
- 1.50 Nurse Practitioners
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
